Role of HSP90 in mediating cross-talk between the estrogen receptor and the Ah receptor signal transduction pathways

被引:30
作者
Caruso, JA
Laird, DW
Batist, G
机构
[1] McGill Univ, Sir Mortimer B Davis Jewish Hosp, McGill Ctr Translat Res Canc, Montreal, PQ H3T 1E2, Canada
[2] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada
关键词
Ah receptor; estrogen receptor; HSP90; breast cancer; 2, 3,7,8-tetrachlorodibenzo-p-dioxin; receptor cross-talk;
D O I
10.1016/S0006-2952(99)00225-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Tetrachlorodibenzo-p-dioxin (TCDD)-mediated gene transactivation via the Ah receptor (AhR) has been shown to be dependent upon estrogen receptor (ER) expression in human breast cancer cells. We have investigated the 90-kDa heat shock protein (HSP90) as a mediator of cross-talk between the AhR and the ER signal transduction pathways. The effect of HSP90 overexpression on receptor activity was determined by transient transfection assays using a HSP90 expression vector. Ligand-inducible gene expression was inhibited when the HSP90 expression Vector was cotransfected with a TCDD responsive reporter plasmid. However, overexpression of HSP90 did not block induction of an estrogen-responsive reporter plasmid. To determine whether ER facilitates AhR signaling through its ability to squelch HSP90, two vectors expressing protein products that bind HSP90 were transfected into MDA-MB-231 cells. Introduction of (i) Hell, an ER deletion mutant that does not bind DNA, and (ii) the ligand-binding domain of human AhR, both led to increased basal and TCDD-inducible CYP1A1 expression. Finally, the subcellular distribution of HSP90 was investigated in human breast cancer cell lines. These studies showed HSP90 to be primarily cytoplasmic in ER-positive cell lines, whereas in matched ER-negative cell lines HSP90 was distributed equally between the cytoplasm and nucleus. Taken together, these results demonstrate that HSP90 can regulate AhR activity in vivo, and that Ah responsiveness is dependent upon cellular ER content through a mechanism that involves HSP90. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:1395 / 1403
页数:9
相关论文
共 59 条
[1]  
AKNER G, 1992, EUR J CELL BIOL, V58, P356
[2]  
ANTONSSON C, 1995, MOL CELL BIOL, V15, P756
[3]   2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN INHIBITION OF 17-BETA-ESTRADIOL-INDUCED INCREASES IN RAT UTERINE EPIDERMAL GROWTH-FACTOR RECEPTOR-BINDING ACTIVITY AND GENE-EXPRESSION [J].
ASTROFF, B ;
ROWLANDS, C ;
DICKERSON, R ;
SAFE, S .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1990, 72 (03) :247-252
[4]   COMPARATIVE ANTIESTROGENIC ACTIVITIES OF 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN AND 6-METHYL-1,3,8-TRICHLORODIBENZOFURAN IN THE FEMALE RAT [J].
ASTROFF, B ;
SAFE, S .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1988, 95 (03) :435-443
[5]  
BATIST G, 1986, J BIOL CHEM, V261, P5544
[6]  
BRESNICK EH, 1989, J BIOL CHEM, V264, P4992
[7]   POLYNUCLEAR AROMATIC HYDROCARBON CARCINOGENS AS ANTIESTROGENS IN MCF-7 HUMAN BREAST-CANCER CELLS - ROLE OF THE AH RECEPTOR [J].
CHALOUPKA, K ;
KRISHNAN, V ;
SAFE, S .
CARCINOGENESIS, 1992, 13 (12) :2233-2239
[8]  
CHAMBRAUD B, 1990, J BIOL CHEM, V265, P20686
[9]   DEFINITION OF A MINIMAL DOMAIN OF THE DIOXIN RECEPTOR THAT IS ASSOCIATED WITH HSP90 AND MAINTAINS WILD-TYPE LIGAND-BINDING AFFINITY AND SPECIFICITY [J].
COUMAILLEAU, P ;
POELLINGER, L ;
GUSTAFSSON, JA ;
WHITELAW, ML .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (42) :25291-25300
[10]   SIMILAR BIOCHEMICAL-CHANGES ASSOCIATED WITH MULTIDRUG RESISTANCE IN HUMAN-BREAST CANCER-CELLS AND CARCINOGEN-INDUCED RESISTANCE TO XENOBIOTICS IN RATS [J].
COWAN, KH ;
BATIST, G ;
TULPULE, A ;
SINHA, BK ;
MYERS, CE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (24) :9328-9332